Research and Development
Accord is a leading vertically-integrated global pharmaceutical formulation development, manufacturing, and marketing company headquartered in India, under the parent name of Intas Pharmaceuticals. Our current pipeline spans a full range of dosage forms: orals, topical, transdermal patches, liquids, and lyophilized and peptide injectables.
Accord’s success lies in the cumulative strategic initiatives made in the areas of manufacturing, R & D, biotechnology and global operations for over four decades. Our R & D operation is staffed by a distinguished scientific team with diverse skill sets and educational backgrounds. Our state-of-the-art labs and manufacturing infrastructure provide the right environment for true innovation.
As co-developer of several of the first biosimilar filings in the U.S., we possess not only the R & D and manufacturing expertise required for achieving success with such programs, but also the knowledge required to navigate uncertain regulatory pathways in the regulated markets.
To date, we have commercialized 11 biologic products in the domestic Indian market, and one in the European markets. Continual R & D initiatives in areas such as Oncology, Rheumatology, Nephrology, Ophthalmology, Autoimmune and Plasma -derived therapies have strengthened product pipelines, both niche and complex, in many of the company’s global markets.